Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)
- Diseases (2)
- Medical Specialties (2)
- Pharmaceutical Preparations (2)
- Allergy and Immunology (1)
-
- Amino Acids, Peptides, and Proteins (1)
- Bioethics and Medical Ethics (1)
- Biology (1)
- Endocrine System Diseases (1)
- Endocrinology, Diabetes, and Metabolism (1)
- Genetic Phenomena (1)
- Genetics (1)
- Genetics and Genomics (1)
- Health Services Administration (1)
- Health Services Research (1)
- Hematology (1)
- Hemic and Lymphatic Diseases (1)
- Immune System Diseases (1)
- Immunology and Infectious Disease (1)
- Immunopathology (1)
- Immunotherapy (1)
- Life Sciences (1)
- Medical Biochemistry (1)
- Medical Education (1)
- Keyword
-
- Aspirin (2)
- Ibuprofen (2)
- Over-the-counter (2)
- Painkillers (2)
- Paracetamol (2)
-
- Risks (2)
- 3rd level students (1)
- AHUS (1)
- Anaemia (1)
- Anaphylaxis (1)
- BRCA (1)
- COVID-19 (1)
- CTTP (1)
- Cancer (1)
- Checkpoint inhibitors (1)
- Coagulopathy (1)
- Coronavirus (1)
- Cytokine storm (1)
- DHUS (1)
- Diabetes (1)
- Dialysis (1)
- Dietetic service (1)
- Eculizumab (1)
- Emicizumab-kxwh (1)
- FVIII (1)
- Food allergen (1)
- Food allergy (1)
- Gene (1)
- Genetic screening (1)
- Haemolysis (1)
Articles 1 - 3 of 3
Full-Text Articles in Patient Safety
Emicizumab-Kxwh: A Critical Review, Kiera O'Leary
Emicizumab-Kxwh: A Critical Review, Kiera O'Leary
International Undergraduate Journal of Health Sciences
The first descriptions of haemophilia A were reported in the second century AD, with the first modern description by John Conrad Otto in 1803. Historically, the natural history of haemophilia A was associated with very high rates morbidity and mortality, often following trivial accidents. Although treatment options for haemophilia A have been revolutionised in recent decades, haemophilia A remains a hereditary disease of concern and factor replacement products remain the mainstay of treatment.
As such, patients with haemophilia can carry huge burdens, particularly when a complication such as a FVIII inhibitor is present. A recently approved novel therapeutic, Emicizumab-kxwh, has …
An Investigation Into Over The Counter Painkiller Use, Shane M. Cusack, Angeline D. Lagali, Andreia Stavrianos
An Investigation Into Over The Counter Painkiller Use, Shane M. Cusack, Angeline D. Lagali, Andreia Stavrianos
International Undergraduate Journal of Health Sciences
This study comprises a survey to examine the use, risks, and awareness of over-the-counter (OTC) pain medication. The survey was a paper-based survey extended to the general public in Cork, Ireland from February 24th 2020 to March 14th 2020. A Microsoft Excel template (16.34 2020) was used to analyse the results of the 106 valid responses that were received. Responses showed that 105/106 individuals had taken an OTC painkiller in their lifetime. Paracetamol was the most used OTC painkiller with 98.1% of people having taken it in the past. The overall majority of individuals were aware of …
Full Issue: The International Undergraduate Journal Of Health Sciences, Volume 1, Issue 1, June 2021
Full Issue: The International Undergraduate Journal Of Health Sciences, Volume 1, Issue 1, June 2021
International Undergraduate Journal of Health Sciences
The full June 2021 issue (Volume 1, Issue 1) of the International Undergraduate Journal of Health Sciences